SIGMA Pharmaceuticals today
said that it had received a “nonbinding,
indicative and conditional
proposal” to acquire all of its issued
capital (PD breaking news).
The proposed deal, from an
unnamed suitor, quotes a price of
$0.60 per share - almost twice the
current level of around 35c, where
Sigma is languishing following its
profit downgrade and the
resignation of key executives and
board members incl former ceo
Elmo de Alwis.
Sigma’s board advised
shareholders to take no action on
the bid at this stage.The above article was sent to subscribers in Pharmacy Daily's issue from 21 May 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 May 10
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.